Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 2c; updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ZBH Hot Sheet
Join SI Premium – FREE
Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.90, $0.02 better than the analyst estimate of $1.88. Revenue for the quarter came in at $2.06 billion versus the consensus estimate of $2.04 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2026 EPS of $8.50-$8.60, versus the consensus of $8.54.
For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q1 EPS by 2c; Offers Guidance
- Lemaitre Vascular (LMAT) Misses Q3 EPS by 4c ; Offers Guidance
- Miller Industries (MLR) Misses Q3 EPS by 11c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
